Lumenis EMEA launches international Stellar day – The M22 Day

Lumenis EMEA Announces the Launch of International Stellar Day – Celebrating Innovation in Aesthetic Medicine
May 22, 2025 marks the first-ever EMEA celebration of the Stellar M22 platform and its impact on skin health.

[May 22, 2025] – Lumenis, the global leader in energy-based medical solutions, proudly announces the launch of International Stellar Day, to be celebrated annually on May 22, beginning in 2025. The initiative, introduced by Lumenis EMEA, is dedicated to recognizing the global impact of the Stellar M22 – the company’s flagship multi-application platform for aesthetic and dermatological treatments.

Celebrated by clinics, doctors, and partners across Europe, the Middle East, and Africa, International Stellar Day shines a spotlight on the power of light-based technology to transform patient care in non-invasive aesthetic medicine.

“The Stellar M22 has become more than a device – it’s a global standard in advanced IPL and skin rejuvenation,” said Tuvya Klughaupt, Vice President of Lumenis EMEA. “International Stellar Day is our way of honoring the innovation behind the platform, and the experts who use it every day to deliver exceptional outcomes.”

Highlights of International Stellar Day 2025:

  • Exclusive educational webinars and live demonstrations from leading aesthetic physicians
  • Social media campaign using the hashtag #M22Day
  • Special training events hosted by Lumenis and its distribution partners across key markets
  • Release of official animation and visuals marking May 22 as a milestone in the calendar for skin health professionals

The Stellar M22 is widely used by dermatologists and aesthetic clinics worldwide for treating vascular lesions, pigmentation, skin texture issues, and more. With its modular design and proprietary OPT™ technology, it has set a new benchmark in patient satisfaction and clinical versatility.

About Lumenis
Lumenis is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology, and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). For 50 years, Lumenis’ ground-breaking products have redefined medical treatments and have set numerous technological and clinical gold-standards. Lumenis has successfully created solutions for previously untreatable conditions, as well as designed advanced technologies that have revolutionized existing treatment methods. visit:  www.lumenis.co.uk